Expert opinion on biological therapyRanibizumabBiosimilar PharmaceuticalsHumansIndiaRetrospective Studies
Ranibizumab biosimilar (Oceva) - real-world experience from India (RORE study).
Ashish Sharma, Jay Sheth, Chitaranjan Mishra, Debdulal Chakraborty, Bhagyashree Meshram, Somy Purohit, International Retina Biosimilar Study Group (Inter BIOS Group)
Published: 202510.1080/14712598.2025.2606897
Abstract
BACKGROUND: To evaluate early real-world clinical outcomes on the safety and efficacy of the ranibizumab biosimilar (Oceva, Sun Pharmaceuticals, India). RESEARCH DESIGN AND METHODS: A multicenter, retrospective, uncontrolled observational study evalu…
Preview only. Read the full abstract at the source